journal article·2026-04-21

Engineered Bacillus Calmette-Guérin Mediated Immunotherapy of Triple-Negative Breast Cancer

Weinan Zhang, Hui Shen, Yechun Jiang, Xianyu Huang, Litao Liu, Shu Fang, Yayun Wu, Zhaoyou Chu, Wanni Wang, Haisheng Qian

ACS Nano· Volume 20· Issue 15
Publisher page

Abstract

Live bacterial therapy has shown promise in inducing antitumor immunity, but its efficacy is often limited by the immunosuppressive tumor microenvironment (TME) and insufficient tumor-specific T cell activation. In this study, core–shell Au@Zn x Mn 1– x S nanoparticles (AZMS) were synthesized and covalently conjugated to Bacillus Calmette–Guérin (BCG) to generate the engineered bacterium AZMB, which was subsequently encapsulated within a hyaluronic acid-based matrix to fabricate the functional implant AZMB-IM. Upon percutaneous administration via a puncture needle, BCG acts as a potent immune initiator, significantly enhancing the recruitment of M1-type macrophages and natural killer cells to the tumor site, and also induced the maturation of dendritic cells. Concurrently, AZMB dissociates in the TME, releasing Zn 2+ and Mn 2+ ions. Zn 2+ disrupts the mitochondrial membrane potential, triggering a reactive oxygen species (ROS) storm and inducing immunogenic cell death (ICD). Meanwhile, Mn 2+ amplifies the ROS effect via a Fenton-like reaction and activates the cGAS–STING signaling pathway, which in turn drives robust T cell-mediated antitumor immunity. Collectively, through synergistic activation of innate immunity and ICD-driven adaptive immune responses, AZMB-IM remodels the TME and enhances antitumor immunity, highlighting its significant potential for clinical translation in the treatment of advanced and metastatic solid tumors.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Cancer Research and Treatments · interferon and immune responses · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Biomedical Engineering, Anhui Provincial Institute of Translational Medicine

Anhui Medical University

Institute of Health and Medicine

Hefei Comprehensive National Science Center

Funding

University Natural Science Research Project of Anhui Province · National Natural Science Foundation of China

References (38)

Show source-provided references
1. 10.1056/NEJMra100138910.1056/NEJMra1001389 ↗
2. 10.1038/nrclinonc.2016.6610.1038/nrclinonc.2016.66 ↗
3. 10.1186/s13045-023-01497-310.1186/s13045-023-01497-3 ↗
4. 10.1016/j.bbcan.2022.18867810.1016/j.bbcan.2022.188678 ↗
5. 10.1038/s41523-022-00468-010.1038/s41523-022-00468-0 ↗
6. 10.1038/s41571-021-00565-210.1038/s41571-021-00565-2 ↗
7. 10.1186/s13058-020-01296-510.1186/s13058-020-01296-5 ↗
8. 10.1016/j.canlet.2025.21786510.1016/j.canlet.2025.217865 ↗
9. 10.1186/s12943-023-01850-710.1186/s12943-023-01850-7 ↗
10. 10.1146/annurev-pathol-042420-09323810.1146/annurev-pathol-042420-093238 ↗
11. 10.1038/s44222-023-00119-410.1038/s44222-023-00119-4 ↗
12. 10.1039/D3CS00369H10.1039/D3CS00369H ↗
13. 10.1016/j.cclet.2023.10855710.1016/j.cclet.2023.108557 ↗
14. 10.1002/adma.20230933210.1002/adma.202309332 ↗
15. 10.1002/adfm.20240530410.1002/adfm.202405304 ↗
16. 10.1002/adma.20231073510.1002/adma.202310735 ↗
17. 10.1038/s41551-024-01191-w10.1038/s41551-024-01191-w ↗
18. 10.1021/acsnano.4c1165810.1021/acsnano.4c11658 ↗
19. 10.1038/s41467-023-41768-810.1038/s41467-023-41768-8 ↗
20. 10.1016/j.xcrm.2025.10199510.1016/j.xcrm.2025.101995 ↗
21. 10.1002/adfm.20240438110.1002/adfm.202404381 ↗
22. 10.3390/vaccines905043910.3390/vaccines9050439 ↗
23. 10.3390/pathogens1402019610.3390/pathogens14020196 ↗
24. 10.1002/anie.20221041510.1002/anie.202210415 ↗
25. 10.1016/j.ccr.2023.21504910.1016/j.ccr.2023.215049 ↗
26. 10.1002/adma.20210601010.1002/adma.202106010 ↗
27. 10.1126/sciadv.adr919610.1126/sciadv.adr9196 ↗
28. 10.1021/acsnano.1c0107710.1021/acsnano.1c01077 ↗
29. 10.1021/acsnano.2c0801310.1021/acsnano.2c08013 ↗
30. 10.1038/s41422-020-00395-410.1038/s41422-020-00395-4 ↗
31. 10.1038/s41423-021-00669-w10.1038/s41423-021-00669-w ↗
32. 10.21147/j.issn.1000-9604.2023.01.0410.21147/j.issn.1000-9604.2023.01.04 ↗
33. 10.1021/acs.nanolett.3c0403110.1021/acs.nanolett.3c04031 ↗
34. 10.1021/acs.nanolett.4c0605210.1021/acs.nanolett.4c06052 ↗
35. 10.1021/acsnano.5c0949110.1021/acsnano.5c09491 ↗
36. 10.1126/sciimmunol.adi348710.1126/sciimmunol.adi3487 ↗
37. 10.1038/s43018-025-00986-310.1038/s43018-025-00986-3 ↗
38. 10.1038/s41565-022-01085-510.1038/s41565-022-01085-5 ↗